Application
A. Western blot analysis on 293 cell lysates using anti-Phospho-PKC zeta/lambda (pT410/403) RabMAb (Cat. #AJ1625b), 1:2000 dilution. Cells were either (A) untreated (B) treated with AP.Application
B. Immunohistochemical analysis of paraffin-embedded human brain using anti-Phospho-PKC zeta/lambda (pT410/403) RabMAb (Cat. #AJ1625b),Application
C. Immunofluorescent staining of HeLa cells using anti-Phospho-PKC zeta/lambda (pT410/403) RabMAb (Cat. #AJ1625b).| Product Name | PKC-zeta/lambda Antibody Phospho (pT410/403) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | PRKCZ, PKC2, Protein kinase C zeta type, nPKC-zeta |
| Modification | p-T410/403 |
| Clonality | Monoclonal |
|---|---|
| Clone Number | EP1491Y |
| Host Species | Rabbit |
| Tested Applications | WBIHCIF |
| WB:1:1000 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | PKC2 |
|---|---|
| Alternative Names | PRKCZ PKC2 Protein kinase C zeta type nPKC-zeta |
| Molecular Weight(MW) | 67660 Da |
| Function | Calcium- and diacylglycerol-independent serine/threonine-protein kinase that functions in phosphatidylinositol 3-kinase (PI3K) pathway and mitogen-activated protein (MAP) kinase cascade, and is involved in NF-kappa-B activation, mitogenic signaling, cell proliferation, cell polarity, inflammatory response and maintenance of long-term potentiation (LTP). Upon lipopolysaccharide (LPS) treatment in macrophages, or following mitogenic stimuli, functions downstream of PI3K to activate MAP2K1/MEK1-MAPK1/ERK2 signaling cascade independently of RAF1 activation. Required for insulin-dependent activation of AKT3, but may function as an adapter rather than a direct activator. Upon insulin treatment may act as a downstream effector of PI3K and contribute to the activation of translocation of the glucose transporter SLC2A4/GLUT4 and subsequent glucose transport in adipocytes. In EGF-induced cells, binds and activates MAP2K5/MEK5-MAPK7/ERK5 independently of its kinase activity and can activate JUN promoter through MEF2C. Through binding with SQSTM1/p62, functions in interleukin-1 signaling and activation of NF-kappa-B with the specific adapters RIPK1 and TRAF6 Participates in TNF-dependent transactivation of NF-kappa-B by phosphorylating and activating IKBKB kinase, which in turn leads to the degradation of NF-kappa-B inhibitors. In migrating astrocytes, forms a cytoplasmic complex with PARD6A and is recruited by CDC42 to function in the establishment of cell polarity along with the microtubule motor and dynein. In association with FEZ1, stimulates neuronal differentiation in PC12 cells. In inflammatory response, is required for the T-helper 2 (Th2) differentiation process, including interleukins production, efficient activation of JAK1 and the subsequent phosphorylation and nuclear translocation of STAT6. May be involved in development of allergic airway inflammation (asthma), a process dependent on Th2 immune response. In NF-kappa-B-mediated inflammatory response, can relieve the SETD6-dependent repression of NF-kappa-B target genes by phosphorylating the RELA subunit at 'Ser-311'. Is necessary and sufficient for LTP maintenance in hippocampal CA1 pyramidal cells |
| Tissue Specificity | Expressed in brain, and to a lesser extent in lung, kidney and testis |
| Cellular Localization | Cytoplasm. Endosome. Cell junction. Note=In the retina, localizes in the terminals of the rod bipolar cells (By similarity). Associates with endosomes. Presence of KRIT1, CDH5 and RAP1B is required for its localization to the cell junction |
| Entrez Gene | 5590 |
|---|
Application
A. Western blot analysis on 293 cell lysates using anti-Phospho-PKC zeta/lambda (pT410/403) RabMAb (Cat. #AJ1625b), 1:2000 dilution. Cells were either (A) untreated (B) treated with AP.
Application
B. Immunohistochemical analysis of paraffin-embedded human brain using anti-Phospho-PKC zeta/lambda (pT410/403) RabMAb (Cat. #AJ1625b),
Application
C. Immunofluorescent staining of HeLa cells using anti-Phospho-PKC zeta/lambda (pT410/403) RabMAb (Cat. #AJ1625b).| Application Notes | WB:1:1000 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA. |
